We are live on ! Find out more
XLVS

POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO
XLVS

Delisted

XLVS was delisted on the 22nd of March, 2011.

1 hedge funds and large institutions have $5K invested in POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO in 2019 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 11 (0)

50% less capital invested

Capital invested by funds: $10K → $5K (-$5K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
1
Holders Change
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
NR
Newfound Research
Massachusetts
-$6.54K
Name Holding Trade Value Shares
Change
Change in
Stake
NR
1
Newfound Research
Massachusetts
$5K -$6.54K -51 -57%

XLVS Hedge Fund Activity: Q4 2019 in Review

1 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO (XLVS) for Q4 2019, worth a combined $5K — down 50% from $10K a quarter earlier.

Fund positioning in XLVS was balanced in Q4 2019: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.

The largest seller was Newfound Research, cutting an estimated $6.54K.

  • 1 institutional investor held POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO (XLVS) as of Q4 2019, unchanged from Q3 2019.
  • Funds reported $5K of POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO stock for Q4 2019, down 50% quarter-over-quarter.
  • 0 funds opened new POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO positions in Q4 2019 and 0 closed out.
  • The largest POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO seller in Q4 2019 was Newfound Research, an estimated $6.54K sold.

Based on aggregated 13F filings for Q4 2019.